The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- Twice-daily radiation linked to better quality of life in lung cancer trialon August 30, 2026 at 12:30 am
Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer were reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival (OS) for this patient population.
- Next generation theranostic pair offers new strategy to detect and treat metastatic kidney canceron August 29, 2026 at 10:30 pm
A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC). Using a small-molecule compound, the new approach helps mitigate toxicity issues common with treatment, offering a safe and feasible strategy for those with end-stage disease. This research was published in the September issue of The Journal of Nuclear Medicine.
- Physical exams alone may not reliably diagnose pneumonia in children, national study findson August 29, 2026 at 9:00 pm
When a child has symptoms that could be pneumonia, doctors often listen to the child’s lungs with a stethoscope to help make a diagnosis. But a new national study led by physician-scientists at Ann & Robert H. Lurie Children’s Hospital of Chicago and PECARN finds that doctors may not always hear or interpret the same things when examining the same child, illustrating limitations of the physical examination.
- Implantable cardioverter-defibrillators may benefit certain younger patients with mild–moderate heart dysfunctionon August 29, 2026 at 9:00 pm
A more than a decade-long medical trial has opened the way for potentially life-saving treatment options for patients with mild-to-moderate heart conditions. Internationally recognized cardiac expert Flinders University Professor Joseph Selvanayagam, from Adelaide’s Heart & Vascular, presented his findings at the European Society of Cardiology Congress (ESC 2026) in Munich on Friday. The breakthrough has also been published in JAMA.
- New philosophical framework reframes moral distress in health careon August 29, 2026 at 6:00 pm
Nurses and physicians often recognize what kind of care a patient deserves at a given moment, whether it is more time at the bedside, a change in pain management or a detailed conversation about the goals of a specific treatment. However, these health care professionals sometimes find themselves unable to follow through because of external factors, ranging from understaffing and resource shortages to institutional policies and regulations.




